Hepatitis C Virus Relapse After Ultrashort Direct-Acting Antiviral Therapy Associates With Expression of Genes Involved With Natural Killer-Cell and CD8(+) T-Cell Function

To identify immunologic correlates of hepatitis C virus (HCV) relapse after direct-acting antiviral (DAA) therapy, we quantified select immune transcripts in whole blood from noncirrhotic HCV subjects treated with 4–6 weeks of DAAs. We identified specific markers of natural killer-cell and CD8(+) T-...

Descripción completa

Detalles Bibliográficos
Autores principales: Orr, Cody, Masur, Henry, Kottilil, Shyam, Meissner, Eric G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082583/
https://www.ncbi.nlm.nih.gov/pubmed/33959672
http://dx.doi.org/10.1093/ofid/ofab118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082583/
https://www.ncbi.nlm.nih.gov/pubmed/33959672
http://dx.doi.org/10.1093/ofid/ofab118

Ejemplares similares